Live Breaking News & Updates on Aimmune therapeutics

Stay informed with the latest breaking news from Aimmune therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Aimmune therapeutics and stay connected to the pulse of your community

Seasonal Allergy Market Gears Up to Surpass US$ 2.58 Billion by 2033

Seasonal Allergy MarketAccording to Future Market Insights most recent industry report, the global seasonal allergies market sales is expected to be valued US$ 1.15 billion in 2022. It is anticipated that the market would expand at a 7.8% compound annual growth rate (CAGR) and reach an estimated US$ 2.58 billion in...

New-york , United-states , South-korea , Delaware , America , Stallergenes-greer , Johnson , Meda-pharmaceuticals-inc , Route-of-administration , Market-insights-inc , Merck-kga , Astrazeneca

Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155

VOWST preliminary net sales of approximately $10.4 million for the fourth quarter of 2023

Significant adoption of VOWST since commercial launch in June 2023 through year-end 2023 with 2,833...

Terri-young , Eric-shaff , Seres-therapeutics-inc , Most-influential-companies , Aimmune-therapeutics-inc , Nasdaq , Exchange-commission , Health-science , Seres-therapeutics , Track-designation , Healthcare-conference , Chief-executive-officer

Vera Therapeutics Announces Appointment of Industry

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and...

Stanford-university , California , United-states , Brisbane , Queensland , Australia , Joyce-allaire , Orionis-biosciences , Celia-lin , Marshall-fordyce , Williamd-turner , Mari-purpura

Vera Therapeutics, Inc. Announces Executive Changes

Vera Therapeutics, Inc. announced the appointments of two industry veterans to help lead the development of the company?s drug programs including its late-stage product candidate, atacicept, to treat...

California , United-states , Stanford-university , Williamd-turner , Robertm-brenner , Orionis-biosciences , Celia-lin , Albert-einstein-college-of-medicine , Vera-therapeutics-inc , Astrazeneca , Regulatory-affairs , California-state-university-at-long-beach

Seasonal Allergy Market Gears Up to Surpass US$ 2.58 Billion by 2033-FMI Study

Seasonal Allergy MarketThe most recent industry analysis by Future Market Insights places the worldwide seasonal allergy market estimated worth at US$ 1.15 billion in 2022. The market is predicted to develop at a compound annual growth rate (CAGR) of 7.8% to reach an estimated valuation of US$ 2.58 billion in 2033.C...

United-states , Delaware , New-york , South-korea , America , Stallergenes-greer , Market-insights-inc , Allergy-group , Meda-pharmaceuticals-inc , Merck-kgaa , Astrazeneca , Allergan-inc

Seres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST Net Sales of $7.6 Million

02.11.2023 - Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported financial results for the third quarter ended September 30, 2023, including VOWST net sales of $7.6 million. Third quarter VOWST commercial results ...

Aimmune-therapeutics-inc , Nestle , Nasdaq , Exchange-commission , Seres-therapeutics-inc , Health-science , Cost-savings , Term-loan-facility , Oaktree-capital-management , Aimmune-therapeutics , Full-prescribing-informationandpatient

Global Allergy Immunotherapy Market to Exceed US$ 4.07 Billion by 2033, Riding on the Wave of 8.9% C

FMI, a leading market research and analysis firm, forecasts a significant upswing in the Global Allergy Immunotherapy Industry. In 2023, the market is set to reach an estimated value of US$ 1.74 billion, with a remarkable compound annual growth rate (CAGR) of 8.9% projected from 2023 to 2033. By 2033, the market is...

Delaware , United-states , Spain , China , New-york , Canada , Italy , United-kingdom , Germany , America , Stallergenes-greer , Allergy-association-of-america

allergy immunotherapy market is expected to surpass the US$ 4.07 Billion mark by 2033, at an impress

FMI’s projections indicate that the worldwide allergy immunotherapy market is on a trajectory to attain a valuation of approximately US$ 1.74 billion in 2023. Demonstrating robust growth at an impressive compound annual growth rate (CAGR) of 8.9% from 2023 to 2033, the market is expected to surpass the US$ 4.07 bill...

New-york , United-states , Spain , Germany , China , United-kingdom , Canada , Delaware , Italy , America , Stallergenes-greer , Allergy-association-of-america

Biotech Cerus Corporation appoints new CHRO Alicia Goodman

'I'm making sure that the people in those positions are able to be as successful as possible'

California , United-states , Alicia-goodman , Novartis , Nestle-health-science , Cerus-corporation , Millendo-therapeutics , Aimmune-therapeutics , Hr , Hro , Iotech ,

Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer

CONCORD, Calif.--(BUSINESS WIRE)--Sep 27, 2023--

California , United-states , Jessica-hanover , Alicia-goodman , Cerus-corporation , Linkedin , Corporate-affairs , Company-executive-leadership-team , Nestle-health-science , Cerus-corporation-nasdaq , Chief-human-resources-officer , Executive-leadership